CD44 and ovarian carcinoma: Another third-generation anti CD44+ CAR engineered NK cells showed strong cytotoxic activity against CD44+ ovarian cancer SKOV3 and OVCAR3 cell lines and primary ovarian cancer cells harvested from ascites, compared to CD44-negative A2780 cells.